HIV/AIDS situation in Serbia

GORDANA J. DRAGOVIĆ LUKIĆ, MD, PhDDepartment of Clinical Pharmacology, Pharmacology and Toxicology;

School of Medicine, University of Belgrade, Belgrade, Serbia

IT

BiH

MN

HR

HRO

BG

MK

AL

GRTR

SLO

SERBIA

A

Belgrade, Serbia

Current Epidemiological HIV/AIDSSituation in Serbia

■ HIV prevalence (case registration by the end of June 2010.):

2414 cumulative

1472 AIDS

962 died

1382 PLWHA

■ HIV testing prevalence very low: 1.5/1000

(6 -11x higher numbers - “real life”)

■ Since 1987 mandatory HIV testing

Current Epidemiological HIV/AIDSSituation in Serbia

■ Of all HIV/AIDS

cases in 2010:

47% IDUs

62% MSM

31% heterosexual

■ HAART introduced

by the public health

insurance system in 1997.

Currently available antiretroviral drug in Serbia ■ NRTI

AZT, ZDV Zidosan®

ddI Videx EC®

ddI Videx EC®

d4T Zerit®

d4T Zerit®

3TC Epivir®

ABC Ziagen®

3TC/ZDV Combivir®

TDF/FTC Truvada®

ABC/3TC Kivexa®

■ NNRTI

EFV Stocrin®

NVP Viramune®

ETV Intelence®

Currently available antiretroviral drug in Serbia

■ PI

LPV/r Aluvia®

IDV Crixivan®

RTV Norvir®

SQV Invirase®

FPV Telzir®

DRV Prezista®

■ II

RLG Isentress®

■ R5

MVC Celsentri®

■ IF

T-20 Fuzeon®

Beograd

HIV/AIDS Centers in Serbia

■ Beograd (890 pts)

■ Novi Sad (76 pts)

■ Nis (54 pts)

■ Kragujevac (4 pts)

Novi Sad

Nis

Kragujevac

Previous responses to HIV/AIDS Challenge

■ 2002 National Commission to fight

HIV/AIDS

■ 2005-2010 National Strategy for the

fight against HIV/AIDS in Serbia

■ 2006 National Office for HIV/AIDS

■ 2010-2015 National Strategy for the

fight against HIV/AIDS in Serbia

Main achievements in the

last few years:

Previous responses to HIV/AIDS Challenge

Main achievements in the

last few years:

■ 2007 National Guideline for

Clinical Management and

Treatment of HIV Infection

■ 2008 Candle light memorial day

■ 2009 Antidiscrimination law

■ May 2009 New EACS

Guidelines version addopted as

a National Guidelines

2008 Candle light memorial day